99mTechnetium-labeled cardiac scintigraphy for suspected amyloidosis: a review of current and future directions
Heart Failure Reviews · 2022-09 · 27 (5) · 1493-1503
DOI: 10.1007/s10741-021-10174-x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Heart Failure Reviews, online erschienen am 28.10.2021. Verfasst von Jean Michel Saad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Houston Methodist Debakey Heart & Vascular Center, Houston, TX, USA. Hauptthemen laut MEDLINE: Amyloidosis, Cardiomyopathies. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 63 Literaturangaben.
Abstract (Originalsprache)
Cardiac amyloidosis (CA) is an underdiagnosed form of restrictive cardiomyopathy leading to a rapid progression into heart failure. Evaluation of CA requires a multimodality approach making use of echocardiography, cardiac magnetic imaging, and nuclear imaging. Technetium (Tc)-labeled cardiac scintigraphy has witnessed a resurgence in its application for the workup of CA. Advancements in disease-modifying therapies have fueled the rapid adoption of cardiac scintigraphy using bone tracers and the need for transformative novel studies. The goal of this review is to present diagnostic utility, currently recommended protocols, as well as a glimpse into the rapid evolution of Tc-labeled cardiac scintigraphy in the diagnosis of CA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Houston Methodist Debakey Heart & Vascular Center, Houston, TX, USA.
- Crozer Keystone Health System, Upland, PA, USA.
- Houston Methodist Debakey Heart & Vascular Center, Houston, TX, USA. mal-mallah@houstonmethodist.org.
ORCID-Profile: Jean Michel Saad, Ahmed Ibrahim Ahmed, Mouaz H Al-Mallah
Zitieren
APA
Saad, J. M., Ahmed, A. I., Han, Y., Saeed, S., Pournazari, P., & Al-Mallah, M. H. (2022). 99mTechnetium-labeled cardiac scintigraphy for suspected amyloidosis: a review of current and future directions. Heart Failure Reviews, 27(5), 1493-1503. https://doi.org/10.1007/s10741-021-10174-x
Vancouver
Saad JM, Ahmed AI, Han Y, Saeed S, Pournazari P, Al-Mallah MH. 99mTechnetium-labeled cardiac scintigraphy for suspected amyloidosis: a review of current and future directions. Heart Failure Reviews. 2022;27(5):1493-1503. doi:10.1007/s10741-021-10174-x
BibTeX
@article{Saad2022,
author = {Saad, Jean Michel and Ahmed, Ahmed Ibrahim and Han, Yushui and Saeed, Subha and Pournazari, Payam and Al-Mallah, Mouaz H},
title = {99mTechnetium-labeled cardiac scintigraphy for suspected amyloidosis: a review of current and future directions},
journal = {Heart Failure Reviews},
year = {2022},
volume = {27},
number = {5},
pages = {1493--1503},
doi = {10.1007/s10741-021-10174-x}
}
EUVIMED